Cerity Partners’s GoodRx Holdings GDRX Stock Holding History

Cerity Partners’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Buy	89,232 +35,306	+65%	+$89.7K	﹤0.01%	2902
2026 Q1	$106K	Buy	53,926 +15,759	+41%	+$37K	﹤0.01%	3019
2025 Q4	$103K	Buy	38,167 +20,493	+116%	+$67.3K	﹤0.01%	2741
2025 Q3	$74.8K	Buy	+17,674	New	+$77.7K	﹤0.01%	2657
2022 Q1	–	Sell	-8,709	Closed	-$285K	–	1003
2021 Q4	$285K	Buy	8,709 +9	+0.1%	+$362	﹤0.01%	793
2021 Q3	$357K	Buy	+8,700	New	+$316K	0.01%	531

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Cerity Partners's GDRX Position: Q2 2026 in Review

Cerity Partners increased its GoodRx Holdings (GDRX) stake by 65% in Q2 2026, buying an estimated $89.7K and bringing the position to 89,232 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Cerity Partners first reported a position in GDRX in Q3 2021 and has held it in 6 quarters since. The position peaked at $357K in Q3 2021. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Cerity Partners held 89,232 shares of GoodRx Holdings worth $257K as of Q2 2026.
Cerity Partners bought 35,306 GoodRx Holdings shares in Q2 2026, an estimated $89.7K.
GoodRx Holdings made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2902 holding.
Cerity Partners first reported a position in GoodRx Holdings in Q3 2021 and has held it in 6 quarters since.
Cerity Partners's GoodRx Holdings position peaked at $357K in Q3 2021.
163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.